Vít Martin Matějka

G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab

Ondřej Fiala, Tomáš Büchler, Beatrice Mohelníková-Duchoňová et al. · Tumor Biology · 2015 · 54 citations

Medicine, Genetics, Oncology +17

Tissue reaction to three different types of tissue glues in an experimental aorta dissection model: a quantitative approach

Kirsti Witter, Zbyněk Tonar, Vít Martin Matějka et al. · Histochemistry and Cell Biology · 2009 · 43 citations

Medicine, Bioengineering, Surgery +15

Cytokeratin serum biomarkers in patients with colorectal cancer.

Stefan Holdenrieder, P Stieber, Václav Liška et al. · PubMed · 2012 · 32 citations

Medicine, Oncology, Pathology +17

Post‐treatment recovery of suboptimal DNA repair capacity and gene expression levels in colorectal cancer patients

Jana Slyšková, Francesca Cordero, Barbara Pardini et al. · Molecular Carcinogenesis · 2014 · 21 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

The role of cetuximab in the treatment of metastatic colorectal cancer.

L Holubec, Václav Liška, Vít Martin Matějka et al. · PubMed · 2012 · 18 citations

Medicine, Oncology, Pharmacology +16